LWLaura WatersMD, FRCPVideoHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Laura Waters | Weight Gain and ARV Therapy: What a Clinician Needs to KnowView Video
DGDeniz GökenginMD, PhDVideoHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Deniz Gökengin | Prevention of STIs: The Role of Doxy-PEPView Video
AMGAnna Maria GerettiMD, PhD, FRCPathVideoHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Anna Maria Geretti | Resistance Considerations in Choosing PrEP Across EuropeView Video
MMMichael MeulbroekVideoHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Michael Meulbroek | The Role of Social and Structural Determinants on Access to PrEPView Video
AWAnnemarie WensingMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Andrea De Luca Lecture - Low Level Viremia: Is It Clinically Relevant? | Annemarie WensingView Slideset
DADaniele ArmeniaPhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Charles Boucher Lecture - Resistance Testing in Routine Care: What a Clinician Needs to Know | Daniele ArmeniaView Slideset
LWLaura WatersMD, FRCPSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Weight Gain and ARV Therapy: What a Clinician Needs to Know | Laura WatersView Slideset
DGDeniz GökenginMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Prevention of STIs: The Role of Doxy-PEP | Deniz GökenginView Slideset
AMGAnna Maria GerettiMD, PhD, FRCPathSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Resistance Considerations in Choosing PrEP Across Europe | Anna Maria GerettiView Slideset
MMMichael MeulbroekSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024The Role of Social and Structural Determinants on Access to PrEP | Michael MeulbroekView Slideset
TLThuy LeMD, DPhilSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2024Innovation in Fungal Diagnostics_Thuy Le_SlidesetView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2024Preferences for accessing pre-exposure prophylaxis among men who have (...) - Warittha Tieosapjaroen_SlidesetView Slideset
